Biotech Stock Mailbag: Poniard Predictions

Of course, no such deal materialized. It's stuff like this that causes stupid expectations to be set and contributes to Dendreon's volatility.

So Ben, my grasshopper, have patience.

---

I'd like to end on a sad note. This Mailbag is the last edited by my supremely talented and hard-working editor, Samantha Shaddock. Sam -- known lovingly around these parts as Blammo! -- is leaving TheStreet.com today for new and exciting journalistic adventures.

Folks like Sam do not get the credit they deserve, but they are a vital part of this place. Sam worked tirelessly behind the scenes to make writers like me appear way smarter than we really are. (Any stupidity displayed here, however, is my fault entirely.) Her whip-smart headlines, sharp editorial eye and knowledge of all the mysterious workings of our Web publishing system were unparalleled.

I've worked with a lot of editors in my 20-plus years as a journalist. Sam ranks up there among the finest and most dedicated to her craft. I'm going to miss her greatly. I hope you'll join me in wishing Sam the best of luck in the future.

G-dspeed Blammo!

>To order reprints of this article, click here: Reprints